Browse drugs

…nterventions to modify MMPs during DKA, for example, the use of minocycline, which is a potent inhibitor of MMP-9, may represent important …

… (%) None90 (41.3)21 (47.7)0.238 Insulin91 (41.7)19 (43.2)0.481 Metformin81 (37.2)16 (36.4)0.5 Dipeptidyl peptidase-4 inhbitors (DPP4i)47 (…

…lin to achieve recommended target glycated haemoglobin (HbA1c). Insulin injections improve HbA1c but can lead to problematic hypoglycae…

…increased weight (figure 2A, online supplemental table S3). For insulin and ZnT8 autoantibodies, this association was more pronounced i…

…duals at borderline or intermediate risk of ASCVD.16 Similarly, FIB-4 may serve an analogous role in nephrology by identifying patien…

…CI, −0.18 to 0.12) confirmed the non-inferiority of efsitora to glargine. They had predefined a non-inferiority margin of 0.4 percentage…

…is study aimed to establish population-specific RIs for fasting insulin and key insulin-related indices using a direct priori method in…

…38 to 4.81)) and Class C had the highest risk of progressing to insulin (HR=5.67 (4.59 to 7.02)). There was no difference in the risk o…

…ng languages other than English or Spanish, and those requiring insulin had a higher percentage categorized as having “poor glucose con…

…lin and SGLT2 inhibitors, while DPP-4 inhibitors clustered with metformin ( figure 1). Heatmapping confirmed strong phenotype-specific en…

…s clinic for new-onset T1D without DKA 2–5 days after beginning insulin (n=14). Children with chronic T1D and glycated hemoglobin <8.0%…

…solutions, suggesting significant buffering capacity.Conclusion Alprostadil and vancomycin IV solutions are physically compatible with two …